Achieving the Ultimate Physiological Goal in Transition State Analogue Inhibitors for Purine Nucleoside Phosphorylase
Open Access
- 1 August 2003
- journal article
- Published by Elsevier
- Vol. 278 (34), 31465-31468
- https://doi.org/10.1074/jbc.c300259200
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Over-the-Barrier Transition State Analogues and Crystal Structure with Mycobacterium tuberculosis Purine Nucleoside Phosphorylase,Biochemistry, 2003
- Ionic States of Substrates and Transition State Analogues at the Catalytic Sites of N-RibosyltransferasesBiochemistry, 2003
- Inhibition of Uracil DNA Glycosylase by an Oxacarbenium Ion MimicBiochemistry, 2002
- One-Third-the-Sites Transition-State Inhibitors for Purine Nucleoside PhosphorylaseBiochemistry, 1998
- Calf Spleen Purine Nucleoside Phosphorylase Complexed with Substrates and Substrate Analogues,Biochemistry, 1998
- Pre-steady-state transition-state analysis of the hydrolytic reaction catalyzed by purine nucleoside phosphorylaseBiochemistry, 1995
- Structure-based design of inhibitors of purine nucleoside phosphorylase. 1. 9-(Arylmethyl) derivatives of 9-deazaguanineJournal of Medicinal Chemistry, 1993
- Deoxyguanosine toxicity on lymphoid cells as a cause for immunosuppression in purine nucleoside phosphorylase deficiencyCell, 1978
- Deoxyguanosine Triphosphate as a Possible Toxic Metabolite in the Immunodeficiency Associated with Purine Nucleoside Phosphorylase DeficiencyJournal of Clinical Investigation, 1978
- NUCLEOSIDE-PHOSPHORYLASE DEFICIENCY IN A CHILD WITH SEVERELY DEFECTIVE T-CELL IMMUNITY AND NORMAL B-CELL IMMUNITYThe Lancet, 1975